These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16971387)

  • 21. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
    Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
    Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy.
    Ianzano L; Young EJ; Zhao XC; Chan EM; Rodriguez MT; Torrado MV; Scherer SW; Minassian BA
    Hum Mutat; 2004 Feb; 23(2):170-176. PubMed ID: 14722920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.
    Tagliabracci VS; Turnbull J; Wang W; Girard JM; Zhao X; Skurat AV; Delgado-Escueta AV; Minassian BA; Depaoli-Roach AA; Roach PJ
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19262-6. PubMed ID: 18040046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lafora's disease: towards a clinical, pathologic, and molecular synthesis.
    Minassian BA
    Pediatr Neurol; 2001 Jul; 25(1):21-9. PubMed ID: 11483392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli.
    Brewer MK; Husodo S; Dukhande VV; Johnson MB; Gentry MS
    BMC Biochem; 2014 Apr; 15():8. PubMed ID: 24690255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity.
    Dukhande VV; Rogers DM; Romá-Mateo C; Donderis J; Marina A; Taylor AO; Sanz P; Gentry MS
    PLoS One; 2011; 6(8):e24040. PubMed ID: 21887368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
    Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
    Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii.
    Gentry MS; Romá-Mateo C; Sanz P
    FEBS J; 2013 Jan; 280(2):525-37. PubMed ID: 22364389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease.
    Puri R; Suzuki T; Yamakawa K; Ganesh S
    J Biol Chem; 2009 Aug; 284(34):22657-63. PubMed ID: 19542233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laforin and malin knockout mice have normal glucose disposal and insulin sensitivity.
    DePaoli-Roach AA; Segvich DM; Meyer CM; Rahimi Y; Worby CA; Gentry MS; Roach PJ
    Hum Mol Genet; 2012 Apr; 21(7):1604-10. PubMed ID: 22186021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.
    Irimia JM; Tagliabracci VS; Meyer CM; Segvich DM; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2015 Sep; 290(37):22686-98. PubMed ID: 26216881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimerization of Vaccinia virus VH1 is essential for dephosphorylation of STAT1 at tyrosine 701.
    Koksal AC; Cingolani G
    J Biol Chem; 2011 Apr; 286(16):14373-82. PubMed ID: 21362620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The unique evolution of the carbohydrate-binding module CBM20 in laforin.
    Kuchtová A; Gentry MS; Janeček Š
    FEBS Lett; 2018 Feb; 592(4):586-598. PubMed ID: 29389008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.
    Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS
    Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex.
    Luo W; Peterson A; Garcia BA; Coombs G; Kofahl B; Heinrich R; Shabanowitz J; Hunt DF; Yost HJ; Virshup DM
    EMBO J; 2007 Mar; 26(6):1511-21. PubMed ID: 17318175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
    Gentry MS; Worby CA; Dixon JE
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy.
    Dubey D; Ganesh S
    Hum Mol Genet; 2008 Oct; 17(19):3010-20. PubMed ID: 18617530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycogen metabolism in tissues from a mouse model of Lafora disease.
    Wang W; Lohi H; Skurat AV; DePaoli-Roach AA; Minassian BA; Roach PJ
    Arch Biochem Biophys; 2007 Jan; 457(2):264-9. PubMed ID: 17118331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic Insights into Glucan Phosphatase Activity against Polyglucan Substrates.
    Meekins DA; Raththagala M; Auger KD; Turner BD; Santelia D; Kötting O; Gentry MS; Vander Kooi CW
    J Biol Chem; 2015 Sep; 290(38):23361-70. PubMed ID: 26231210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.